Project Grant HT94252510245
Award Date
5/1/25
Completion Date
4/30/27
Dollars Obligated
$403K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Cleveland, OH 44106, USA
Similar Awards
The Department of the Army Medical Command awarded Case Western Reserve University a $402,500 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to support the repurposing of a therapeutic candidate to mitigate synaptopathy and associated hearing loss. The two-year award, beginning September 1, 2021, will fund research activities at Case Western Reserve University and its affiliated University Hospitals of Cleveland location in Cleveland, Ohio to...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $358,245 Project Grant to the Massachusetts Eye And Ear Infirmary on May 15, 2024 for the project "IN SILICO SCREEN AND IN VIVO EVALUATION OF FDA-APPROVED DRUGS TO TREAT NOISE-INDUCED HEARING LOSS". The grant supports a two-year effort to screen FDA-approved drugs and evaluate the most promising compounds for their ability to protect against noise-induced hearing loss in cell...
The Defense Health Agency awarded Creighton University a $367,501.00 Project Grant from the Military Medical Research and Development program (CFDA 12.420) to conduct research on natural product-based therapies against noise-induced hearing loss. The grant period is from September 1, 2023 to August 31, 2025. The research will take place in Omaha, Nebraska. This grant supports the DoD's objective of transforming health care for Service Members and the American public through innovative and...
The U.S. Defense Health Agency awarded a $825,000 Project Grant to Delix Therapeutics, Inc. in Palo Alto, CA under the Military Medical Research and Development program (CFDA 12.420). The funding will support the "DEVELOPMENT OF SMALL-MOLECULE TREATMENT FOR HEARING LOSS" over a 3-year period from June 1, 2024 to May 31, 2027. The Military Medical Research and Development program provides grants to academic institutions, research centers, and medical universities to conduct biomedical...
This $1.42M Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at the University of Miami to prevent hidden hearing loss and synaptopathy following noise overexposure through targeted temperature management. The 3-year grant, awarded on July 15, 2023, will fund this study focused on improving medical solutions for the battlefield and transforming health care for Service Members and the public through...
This federal Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) provides $371,627 to the University of Texas Medical Branch at Galveston (UTMB) to support research on "TARGETING RETINOID ACID METABOLIC PATHWAY TO TREAT NOISE-INDUCED HEARING LOSS". The research aims to investigate the use of selective CYP26 inhibitors as a treatment for noise-induced hearing loss, with potential to transform care for Service Members and...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $1,163,218.00 to Case Western Reserve University's Office of Research Administration Division (doing business as University Hospitals of Cleveland) to conduct research on SLC37A3 as a novel prostate cancer target. The award period runs from July 15, 2024 to July 14, 2028. Through this funding, Case Western Reserve University will carry out...
The U.S. Department of Defense (DoD) Defense Health Agency awarded a $1,820,004 Project Grant to Case Western Reserve University's Office of Research Administration Division, doing business as the University Hospitals of Cleveland, under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "HEMOSEAL: COMBINATORIAL NANOPARTICLE TECHNOLOGY FOR POINT-OF-INJURY HEMORRHAGE CONTROL," will support the development of an innovative nanoparticle-based technology...
The University of Miami received a $1,534,759 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on the "RESTORATION OF INNER EAR CELLS IN THE HEARING LOSS-ASSOCIATED HUMAN INNER EAR SYSTEM". This 3-year award, with a period of performance from September 30, 2023 to September 29, 2026, will support the university's biomedical research efforts focused on developing new treatments and...
The U.S. Department of Defense (DoD) awarded a $497,747 project grant to Case Western Reserve University's Office of Research Administration Division (doing business as University Hospitals of Cleveland) under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a novel, central nervous system-penetrant synthetic oleanane triterpenoid for the treatment of diffuse intrinsic pontine glioma (DIPG), a rare and aggressive form of pediatric brain...